 |
|
Fibrolamellar hepatocellular carcinoma-related hyperammonemic encephalopathy: Up to now and next steps
Rodrigo Cañada Trofo Surjan, Elizabeth Santana dos Santos, Sergio do Prado Silveira, Fabio Ferrari Makdissi, Marcel Autran Cesar Machado
Clin Mol Hepatol. 2020;26(2):231-232. Published online 2019 Nov 4 DOI: https://doi.org/10.3350/cmh.2019.0084
|
|
Citations to this article as recorded by
 Metabolomic analysis of vascular cognitive impairment due to hepatocellular carcinoma
Dan Zhu, Yamei Zhu, Lin Liu, Xiaoxue He, Shizhong Fu
Frontiers in Neurology.2023;[Epub] CrossRef Current Advances in the Treatment of Fibrolamellar Carcinoma of Liver
Jyotsna Gummadi, Xin Wang, Changqing Xie
Journal of Hepatocellular Carcinoma.2023; Volume 10: 745. CrossRef Epidemiological and Clinical Characteristics of Five Rare Pathological Subtypes of Hepatocellular Carcinoma
Xiaoyuan Chen, Yiwei Lu, Xiaoli Shi, Guoyong Han, Long Zhang, Chuangye Ni, Jie Zhao, Yun Gao, Xuehao Wang
Frontiers in Oncology.2022;[Epub] CrossRef
|